Acute Myeloid Leukemia News and Research

RSS
Acute Myeloid Leukemia (AML) is a rapidly progressing cancer of the blood characterized by the uncontrolled proliferation of immature blast cells in the bone marrow. The Leukemia and Lymphoma Society estimates that over 13,000 new cases of AML were diagnosed and approximately 9,000 deaths from AML occurred in the U.S. during 2007. AML is generally a disease of older adults, and the median age of a patient diagnosed with AML is about 67 years. A majority of elderly patients are not considered candidates for standard induction therapy or decline therapy, resulting in an acute need for new treatment options.
A loss in DNS repair function causes acute myeloid leukemia relapse

A loss in DNS repair function causes acute myeloid leukemia relapse

Leukemia relapse stems from DNA repair function loss

Leukemia relapse stems from DNA repair function loss

Kidney cancer drug attacks a major type of acute myeloid leukemia

Kidney cancer drug attacks a major type of acute myeloid leukemia

Molecules might identify high-risk acute-leukemia patients

Molecules might identify high-risk acute-leukemia patients

New test for targeted therapy in acute myeloid leukemia

New test for targeted therapy in acute myeloid leukemia

Discovery of key acute myeloid leukemia gene

Discovery of key acute myeloid leukemia gene

Daisy compound used to attack cancer stem cells

Daisy compound used to attack cancer stem cells

FDA grants orphan drug designation to TREANDA

FDA grants orphan drug designation to TREANDA

Aggressive therapy best for certain acute myeloid leukemia patients

Aggressive therapy best for certain acute myeloid leukemia patients

ERG gene's activity points to more lethal subtype of acute myeloid leukemia

ERG gene's activity points to more lethal subtype of acute myeloid leukemia

Study compares cord blood to bone marrow for transplants

Study compares cord blood to bone marrow for transplants

Patients with myelodysplastic syndromes treated with Revlimid are living longer and remaining transfusion independent

Patients with myelodysplastic syndromes treated with Revlimid are living longer and remaining transfusion independent

Translocation kidney cancer after chemotherapy in childhood

Translocation kidney cancer after chemotherapy in childhood

New discoveries about stem cells in leukemia, breast and colon cancer

New discoveries about stem cells in leukemia, breast and colon cancer

Polymorphisms in the glutathione S-transferase genes and treatment outcomes in acute myeloid leukemia

Polymorphisms in the glutathione S-transferase genes and treatment outcomes in acute myeloid leukemia

Experimental drug provides powerful therapy against acute myeloid leukemia

Experimental drug provides powerful therapy against acute myeloid leukemia

Dasatinib provides significant benefit in chronic myeloid leukemia patients resistant to Gleevec

Dasatinib provides significant benefit in chronic myeloid leukemia patients resistant to Gleevec

ChemGenex Pharmaceuticals receives U.S. orphan drug designation for Ceflatonin

ChemGenex Pharmaceuticals receives U.S. orphan drug designation for Ceflatonin

Study recommends treatment change for pre-leukemia disease

Study recommends treatment change for pre-leukemia disease

Decitabine improves myelodysplastic syndrome treatment

Decitabine improves myelodysplastic syndrome treatment